Analysis of peripheral T-cell lymphoma (PTCL) subtype by race and geography using the Comprehensive Oncology Measures for Peripheral T-Cell Lymphoma Treatment (COMPLETE) dataset
- PMID: 24852789
Analysis of peripheral T-cell lymphoma (PTCL) subtype by race and geography using the Comprehensive Oncology Measures for Peripheral T-Cell Lymphoma Treatment (COMPLETE) dataset
Similar articles
-
Incidence and outcomes of the peripheral T-cell lymphoma subtypes in the United States.Leuk Lymphoma. 2008 Nov;49(11):2099-107. doi: 10.1080/10428190802455867. Leuk Lymphoma. 2008. PMID: 19021052
-
Non-anaplastic peripheral t-cell lymphoma in childhood and adolescence: a Children's Oncology Group study.Pediatr Blood Cancer. 2008 Jul;51(1):29-33. doi: 10.1002/pbc.21543. Pediatr Blood Cancer. 2008. PMID: 18300314 Free PMC article.
-
Enhancing existing approaches to peripheral T-cell lymphoma.Semin Hematol. 2010 Apr;47 Suppl 1:S8-10. doi: 10.1053/j.seminhematol.2010.01.012. Semin Hematol. 2010. PMID: 20359584 Review.
-
Therapy of Peripheral T Cell Lymphoma: Focus on Nodal Subtypes.Curr Oncol Rep. 2020 Apr 16;22(5):44. doi: 10.1007/s11912-020-00902-1. Curr Oncol Rep. 2020. PMID: 32297075 Review.
-
The aggressive peripheral T-cell lymphomas: 2013.Am J Hematol. 2013 Oct;88(10):910-8. doi: 10.1002/ajh.23536. Am J Hematol. 2013. PMID: 24078271 Review.
Cited by
-
The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo.PLoS Pathog. 2015 Sep 17;11(9):e1005142. doi: 10.1371/journal.ppat.1005142. eCollection 2015 Sep. PLoS Pathog. 2015. PMID: 26379282 Free PMC article. Clinical Trial.
-
The Value and Relevance of the T Cell Lymphoma Registries and International Collaborations: the Case of COMPLETE and the T-Cell Project.Curr Hematol Malig Rep. 2015 Dec;10(4):448-55. doi: 10.1007/s11899-015-0291-0. Curr Hematol Malig Rep. 2015. PMID: 26449717 Review.